Page 47 - AN-4-1
P. 47

Advanced Neurology                                                     LLPS in neurodegenerative diseases



            1. Introduction                                    2. Protein aggregation

            Liquid–liquid phase separation (LLPS) is a ubiquitous   Irreversible  protein  aggregates  are  an  important
            phenomenon in biological system that drives the formation   pathological feature of neurodegenerative diseases.
            of membraneless compartments through the phase     Through phase separation, biomolecules can be reversibly
            separation of biomolecules such as proteins, nucleic acids,   separated from the solution into a dense and dilute
            and polysaccharides like glycogen. These compartments   phase. The material properties of droplets assembled by
            often referred to as condensates, arise from multivalent,   LLPS evolve over time. Usually, droplets “age” over time,
            weak, and transient interactions between macromolecules,   characterized by a decrease in droplet dynamics, gelation,
                                                                           5-7
            including protein-protein, protein-RNA, and RNA-RNA   or vitrification.  There are multiple lines of evidence that
            interactions. LLPS is particularly enriched in intrinsically   aging can transform dynamically reversible droplets into
                                                                                          8,9
            disordered regions (IDRs) or low-complexity domains   irreversible solid amyloid fibrils.  The physicochemical
            (LCDs) of proteins, which lack a stable secondary or   characteristics of LLPS are highly suggestive that it could
            tertiary structure, making them highly flexible and prone   act as a key link in the pathophysiological process of
            to phase separation. These regions enable interactions such   protein aggregation. An increasing number of studies
            as π–π stacking, dipole–dipole interactions, cation–anion   have demonstrated that pathological marker proteins for
            interactions, and π–cation interactions, which collectively   neurodegeneration, such as 43  kDa TARDNA binding
                                                                                                     12
            facilitate the reversible formation of liquid-like droplets. 1,2  protein (TDP-43), 10,11  fused in sarcoma (FUS),  Tau, 13,14
                                                                             16
                                                                  15
                                                               Aβ,  Huntingtin  and  α-synuclein (α-Syn), 17,18  share
              LLPS plays  important  roles in  neuronal signaling,
            regulation of transcription and translation, ribosome   certain similarities. LLPS is found to be a critical stage
                                                                                          Through LLPS, the local
                                                               before their aggregation.
                                                                                   5,10-13,17,19
            biogenesis, oxidative stress, and other physiological   concentration  and  volume  crowding  of  biomolecules
            functions of the cell. Neuronal degeneration and   such as proteins and RNA within the condensate phase
            death are characteristic features of neurodegenerative   is significantly  increased,  which  greatly increases the
            diseases. Although the pathogenesis of different types of   probability of nucleation and the risk of fibrillar aggregate
            neurodegenerative diseases varies, a growing number of   formation.  Moreover,  neurodegenerative  pathological
            studies indicate that LLPS plays a key role in the disease   mechanisms such as disease-related mutations, stress, and
            process. In neurodegenerative diseases, such as Alzheimer’s   decreased proteostasis can also significantly affect phase
            disease, Parkinson’s disease, and amyotrophic lateral   separation and abnormal phase transition dynamics,
            sclerosis (ALS), LLPS has been increasingly implicated   which can have an impact on neuronal dysfunction and
            as a key player in pathological protein aggregation and   neurotoxicity. 12,20-24  For example, LLPS-mediated reversible
            cellular dysfunction. Proteins that normally undergo LLPS
            to form functional, dynamic condensates can transition
            into aberrant solid-like aggregates under pathological
            conditions.  This  transition  is  driven  by  mutations,  post-
            translational modifications, or environmental stress,
            leading to the formation of amyloid fibrils or toxic protein
            aggregates characteristic of neurodegenerative disorders. 1,3,4
              The development of neurodegenerative diseases from
            the perspective of LLPS has become an important research
            topic. LLPS is believed to regulate the spatiotemporal
            organization of signaling pathways and gene expression
            in neurons and its dysregulation can contribute to disease
            pathogenesis. Understanding how LLPS influences
            signal  transduction,  gene  stability,  and  condensate
            modulation could provide new therapeutic targets for
            preventing or reversing the aggregation of disease-related
            proteins. This review aims to delve into these key areas –
            protein aggregation, signal transduction, gene stability,
            and condensate modulation – and explore how LLPS
            contributes to both normal cellular function and disease
            states, providing a comprehensive overview of the emerging   Figure 1. Updated understanding of LLPS in neurodegenerative diseases
            role of LLPS in neurodegenerative diseases (Figure 1).  Abbreviation: LLPS: Liquid-liquid phase separation.


            Volume 4 Issue 1 (2025)                         41                               doi: 10.36922/an.4493
   42   43   44   45   46   47   48   49   50   51   52